BioSpace News Archive

Business

EyeGate Pharma Reports Second Quarter 2020 Financial Results and Provides Business Update

EyeGate Pharmaceuticals, Inc. announced financial results for the quarter ended June 30, 2020 and provided an update on recent corporate and operational activities.

August 6, 2020
·
6 min read
Business

Kadmon Provides Business Update and Reports Second Quarter 2020 Financial Results

Kadmon Holdings, Inc. provided a business update and reported financial and operational results for the second quarter of 2020.

August 6, 2020
·
10 min read
Business

Glaukos Corporation Announces Second Quarter 2020 Financial Results

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the second quarter ended June 30, 2020.

August 6, 2020
·
19 min read
Business

Zosano Pharma Announces Partnership Agreement with EVERSANA to Support the Launch and Commercialization of Qtrypta™

Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced it has partnered with EVERSANA, a leading provider of commercial services to the life science industry, to commercialize and distribute Qtrypta™ in the United States.

August 6, 2020
·
6 min read
Business

IntelGenx to Report Second Quarter 2020 Financial Results on August 13, 2020 – Conference Call to Follow

IntelGenx Technologies Corp., a leader in pharmaceutical films, announced that it will release its second quarter 2020 financial results after market close on August 13, 2020.

August 6, 2020
·
3 min read
Deals

Horizon Therapeutics plc Announces Pricing of Public Offering of Ordinary Shares - Aug 07, 2020

Horizon Therapeutics plc announced the pricing of its underwritten public offering of 11,800,000 of its ordinary shares at a price to the public of $71.00 per share.

August 6, 2020
·
4 min read
Business

Establishment Labs Reports Second Quarter 2020 Financial Results

Establishment Labs Holdings Inc., a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced its financial results for the second quarter ended June 30, 2020.

August 6, 2020
·
11 min read
Business

NextCure Reports Second Quarter 2020 Financial Results

NextCure, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, reported second quarter 2020 financial results and provided a business update.

August 6, 2020
·
9 min read
Business

Guardant Health Reports Second Quarter 2020 Financial Results

Guardant Health, Inc., a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, reported financial results for the quarter ended June 30, 2020.

August 6, 2020
·
12 min read
Business

BioLife Solutions Announces Second Quarter 2020 Financial Results

BioLife Solutions, Inc., a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, announced financial results for the three and six months ended June 30, 2020.

August 6, 2020
·
11 min read